Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Mol Cancer Res. 2014 Sep 3;13(1):50–62. doi: 10.1158/1541-7786.MCR-14-0440

Figure 3. Chelerythrine chloride induces TSC2-dependent cell death.

Figure 3

A) Immunoblot analysis of Tsc2+/+ and Tsc2−/− MEFs treated with chelerythrine chloride (2 uM, 2h) or paroxetine (10 uM, 2 h). B) Immunoblot analysis of ELT3-T3 (TSC2-expressing) and ELT-V3 (TSC2-null) cells treated with chelerythrine chloride (6 uM, 3 h). C) Immunoblot of Tsc2+/+ and Tsc2−/− MEFs treated with chelerythrine chloride (2 uM, 2 h).